Fusen Pharmaceutical Co., Ltd.HKEX: 1652

Further extension of completion date of major transaction in relation to deemed disposal of equity interest in henan Fusen Pharmaceutical company limited

· Issued by Fusen Pharmaceutical Co., Ltd. via HKEXnews

Filed with HKEX · Stock code 1652 · · 2 pages · English

Summary by 6ix AI

Fusen Pharmaceutical Co., Ltd. has announced a further extension of the completion date for a major transaction related to the deemed disposal of equity interest in Henan Fusen Pharmaceutical Company Limited. The new completion date for the Capital Increase Price Payment has been extended to a date falling on or before the end of October. This extension is due to the need for additional time for investors to finalize their internal arrangements for payment.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Fusen Pharmaceutical Co., Ltd. on 6ix

Earlier from Fusen Pharmaceutical

All Fusen Pharmaceutical news releases